Responding to an FDA warning - Geographic variation in the use of rosiglitazone

Nilay D. Shah; Victor M. Montori; Harlan M. Krumholz; Karen Tu; G. Caleb Alexander; Cynthia A. Jackevicius

doi:10.1056/NEJMp1011042

Responding to an FDA warning - Geographic variation in the use of rosiglitazone

Nilay D. Shah, Victor M. Montori, Harlan M. Krumholz, Karen Tu, G. Caleb Alexander, Cynthia A. Jackevicius

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	2081-2084
Number of pages	4
Journal	New England Journal of Medicine
Volume	363
Issue number	22
DOIs	https://doi.org/10.1056/NEJMp1011042
State	Published - Nov 25 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMp1011042

Cite this

@article{b2d4c9ceb9c743f69d52c8abd330d1f1,

title = "Responding to an FDA warning - Geographic variation in the use of rosiglitazone",

author = "Shah, {Nilay D.} and Montori, {Victor M.} and Krumholz, {Harlan M.} and Karen Tu and Alexander, {G. Caleb} and Jackevicius, {Cynthia A.}",

year = "2010",

month = nov,

day = "25",

doi = "10.1056/NEJMp1011042",

language = "English (US)",

volume = "363",

pages = "2081--2084",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Responding to an FDA warning - Geographic variation in the use of rosiglitazone

AU - Shah, Nilay D.

AU - Montori, Victor M.

AU - Krumholz, Harlan M.

AU - Tu, Karen

AU - Alexander, G. Caleb

AU - Jackevicius, Cynthia A.

PY - 2010/11/25

Y1 - 2010/11/25

UR - http://www.scopus.com/inward/record.url?scp=78649404322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649404322&partnerID=8YFLogxK

U2 - 10.1056/NEJMp1011042

DO - 10.1056/NEJMp1011042

M3 - Short survey

C2 - 21083379

AN - SCOPUS:78649404322

SN - 0028-4793

VL - 363

SP - 2081

EP - 2084

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 22

ER -

Responding to an FDA warning - Geographic variation in the use of rosiglitazone

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this